Department of Infectious Diseases, Okayama University Hospital, Okayama, 700-8558, Japan.
J Infect Chemother. 2024 Dec;30(12):1324-1326. doi: 10.1016/j.jiac.2024.07.003. Epub 2024 Jul 6.
A recent systematic review and meta-analysis of randomized controlled trials (RCTs) evaluated the efficacy and safety of prolonged versus intermittent β-lactam infusion in adult sepsis patients. The findings revealed a significant decrease in all-cause mortality and marked clinical success in the prolonged infusion group. Unfortunately, however, the manuscript lacked data and discussion for the specific regimens of prolonged β-lactam infusion defined in the included 15 RCT studies, which are herein additionally provided. Excluding one RCT, all protocols adopted a continuous infusion for the prolonged treatment. Except for three RCTs, dosages and timings of bolus injection were clearly defined. The total daily antibiotic dose for the continuous therapy was equivalent to those recommended for intermittent therapy. We believe this supplementary data aids clinicians in providing prolonged β-lactam infusions, contributing to enhanced treatment outcomes for patients suffering from severe sepsis or septic shock.
最近一项针对随机对照试验(RCT)的系统评价和荟萃分析评估了成人脓毒症患者中延长与间歇性β-内酰胺输注的疗效和安全性。研究结果显示,延长输注组的全因死亡率显著降低,临床成功率显著提高。然而,遗憾的是,该研究报告缺乏纳入的 15 项 RCT 研究中所定义的延长β-内酰胺输注具体方案的数据和讨论,这些方案在此额外提供。排除一项 RCT 后,所有方案均采用连续输注进行延长治疗。除了三项 RCT 外,推注的剂量和时间均有明确界定。连续治疗的每日抗生素总剂量与间歇性治疗推荐的剂量相当。我们认为,这些补充数据有助于临床医生提供延长β-内酰胺输注,改善严重脓毒症或感染性休克患者的治疗效果。